News Column

Reports on Drug Delivery Systems from University of Tehran Provide New Insights (Drug targeting using solid lipid nanoparticles)

July 23, 2014



By a News Reporter-Staff News Editor at Biotech Week -- Data detailed on Drugs and Therapies have been presented. According to news originating from Tehran, Iran, by NewsRx correspondents, research stated, "The present review aims to show the features of solid lipid nanoparticles (SLNs) which are at the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery and research. Because of some unique features of SLNs such as their unique size dependent properties it offers possibility to develop new therapeutics."

Our news journalists obtained a quote from the research from the University of Tehran, "A common denominator of all these SLN-based platforms is to deliver drugs into specific tissues or cells in a pathological setting with minimal adverse effects on bystander cells. SLNs are capable to incorporate drugs into nanocarriers which lead to a new prototype in drug delivery which maybe used for drug targeting. Hence solid lipid nanoparticles hold great promise for reaching the goal of controlled and site specific drug delivery and hence attracted wide attention of researchers."

According to the news editors, the research concluded: "This review presents a broad treatment of targeted solid lipid nanoparticles discussing their types such as antibody SLN, magnetic SLN, pH sensitive SLN and cationic SLN."

For more information on this research see: Drug targeting using solid lipid nanoparticles. Chemistry and Physics of Lipids, 2014;181():56-61. Chemistry and Physics of Lipids can be contacted at: Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland. (Elsevier - www.elsevier.com; Chemistry and Physics of Lipids - www.elsevier.com/wps/product/cws_home/506036)

The news correspondents report that additional information may be obtained from E. Rostami, Univ Tehran Med Sci, Endocrine & Metab Res Center, Tehran, Iran. Additional authors for this research include S. Kashanian, A.H. Azandaryani, H. Faramarzi, J.E.N. Dolatabadi and K. Omidfar (see also Drugs and Therapies).

Keywords for this news article include: Iran, Asia, Tehran, Nanoparticle, Nanotechnology, Drugs and Therapies, Drug Delivery Systems, Emerging Technologies

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Biotech Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters